起诉公司，公司可以起诉股东、董事、监事和高 公司，公司可以起诉股东、董事和高级管理人 | 赛隆药业集团股份有限公司 | | | --- | --- | | 《公司章程》修正案 | | | 赛隆药业集团股份有限公司（以下简称"公司"）第四届董事会第十次会议审议通过了 | | | 《关于修订 <公司章程> 的议案》。根据《中华人民共和国公司法》 | | | 《上市公司章程指引（2025 | | | 2024 12 27 年修订）》及中国证券监督管理委员会于 年 月 日发布的《关于新 | <公司法> 配套 | | 制度规则实施相关过渡期安排》相关法律法规的规定，结合公司的实际情况及需求，公司拟 | | | 对《公司章程》相应条款进行修订，具体情况如下： | | | 修订前 修订后 | | | 全文 股东大会 全文 股东会 | | | 第一条 为维护赛隆药业集团股份有限公司 第一条 为维护赛隆药业集团股份有限公司 | | | （以下简称"公司"）、股东和债权人的合法权 （以下简称"公司"）、股东、职工和债权人的合 | | | 益，规范公司的组织和行为，根据《中华人民共 法权益，规范公司的组织和行为，根据《中华 | | ...

Core Points - The articles outline the articles of association for Sailong Pharmaceutical Group Co., Ltd, detailing the company's legal framework, governance structure, and operational guidelines [1][2][3]. Group 1: Company Overview - Sailong Pharmaceutical Group Co., Ltd is established as a joint-stock company in accordance with the Company Law and other relevant regulations [1]. - The registered capital of the company is RMB 176.6 million [2]. - The company is located at 31 Nanwan North Road, Xiangzhou District, Zhuhai, Guangdong Province, with a postal code of 519060 [1]. Group 2: Governance Structure - The legal representative of the company is elected by the board of directors and must be a director or the general manager [2]. - The company’s assets are divided into equal shares, and shareholders are liable for the company's debts only to the extent of their subscribed shares [2][3]. - The articles of association serve as a legally binding document for the company, shareholders, directors, and senior management [2]. Group 3: Business Objectives and Scope - The company's business objective is to enhance management levels and core competitiveness while providing quality services to customers and maximizing shareholder value [3]. - The business scope includes drug production, wholesale, food production, medical devices, and related services, subject to legal approvals [3][4]. Group 4: Share Issuance and Management - The company issues shares in the form of stocks, with each share having a par value of RMB 1 [5][6]. - The total number of shares issued by the company is 176 million, all of which are ordinary shares [5]. - The company cannot provide financial assistance for the purchase of its shares in any form [5]. Group 5: Shareholder Rights and Responsibilities - Shareholders have the right to receive dividends, attend meetings, supervise company operations, and transfer their shares [9][10]. - Shareholders must comply with laws and the articles of association, and they are liable for any damages caused by the abuse of their rights [13][39]. - The company must maintain transparency and provide necessary information to shareholders regarding their rights and the company's operations [10][12]. Group 6: Shareholder Meetings - The company holds annual and temporary shareholder meetings, with specific procedures for calling and conducting these meetings [18][19]. - Shareholder proposals must be submitted in writing and can be made by shareholders holding at least 1% of the shares [23][24]. - Decisions at shareholder meetings require a majority or supermajority vote, depending on the nature of the resolution [78][80].

General Overview - The company has established an Audit Committee to enhance the decision-making function of the Board and ensure effective supervision of the management team [1][2] - The Audit Committee is responsible for reviewing financial information, supervising internal and external audits, and ensuring compliance with relevant laws and regulations [1][3] Composition of the Audit Committee - The Audit Committee consists of three directors, including two independent directors, with at least one being a professional accountant [2][3] - The members are nominated by the Chairman or a majority of independent directors and elected by the Board [2] Responsibilities and Authority - The main responsibilities of the Audit Committee include supervising external audit work, evaluating internal audit performance, and guiding the establishment of internal audit systems [2][3][4] - The Committee must approve significant financial disclosures and the hiring or dismissal of external auditors before submission to the Board [3][4] Internal Audit Oversight - The internal audit department reports directly to the Audit Committee and is responsible for daily operations and communication [2][6] - The Committee oversees the internal audit's effectiveness, reviews annual plans, and ensures compliance with internal control standards [6][7] External Audit Supervision - The Audit Committee is tasked with evaluating the performance of external auditors and ensuring their independence from the company [5][6] - It must propose the hiring or replacement of external auditors and review their fees and terms of engagement [5][6] Meeting Procedures - The Audit Committee meets at least quarterly, with provisions for additional meetings as necessary [12][14] - Decisions require a majority vote from members present, and meetings must be documented with records maintained by the company [12][14] Reporting and Accountability - The Audit Committee is accountable to the Board and must report on its activities and findings, including any significant issues identified during audits [11][35] - It has the authority to propose the convening of temporary Board or shareholder meetings if necessary [20][21] Compliance and Legal Authority - The Audit Committee has the right to inspect financial records and supervise the actions of directors and senior management [18][19] - It can recommend the dismissal of directors or senior management for violations of laws or regulations [19][22]

Core Points - The document outlines the rules for the board of directors of Sailong Pharmaceutical Group Co., Ltd, aiming to standardize meeting procedures and decision-making processes [2][3] - The board consists of 9 directors, including 1 chairman and 3 independent directors, with specific powers and responsibilities defined [2][3] - The chairman is authorized to convene meetings and oversee the execution of board resolutions [3][4] Group 1 - The board must hold at least 2 meetings annually, with specific protocols for notifying members about meetings [4][5] - Meeting notifications must include essential details such as date, location, agenda, and must be sent in advance [4][5] - A quorum requires the presence of more than half of the directors, and provisions are made for proxy attendance [5][6] Group 2 - Decisions require a majority vote from the directors present, with specific rules for abstentions and conflicts of interest [9][10] - The board must adhere to the company's articles of association and cannot exceed the authority granted by the shareholders [9][12] - Meeting records must be maintained, including attendance, proposals discussed, and voting results, with a retention period of 10 years [11][31]

8月10日晚，*ST赛隆（002898）公告称，因公司控制权已发生变更，公司第四届董事会所有成员和部 分高管均递交了辞职报告。 和高涨的股价相对比的却是惨淡的财报。上市公司财报显示，该公司2025年中报预亏1300万—1800万， 净利润同比最高-1120%。2024年净利润亏3315万，同比-448%。 赛隆药业董监高"大换血"，董事会集体辞职 公告显示，蔡南桂先生申请辞去董事长、董事、总裁、战略决策委员会主任委员职务，但将继续担任公 司其他职务。 董事唐霖女士申请辞去董事、战略决策委员会委员、审计委员会委员职务，辞职后不再担任公司任何职 务。 董事兼常务副总裁刘达文先生申请辞去公司董事、常务副总裁、战略决策委员会委员、提名委员会委 员、薪酬与考核委员会委员职务，辞去上述职务后将继续在公司工作。 董事兼副总裁李剑峰先生申请辞去公司董事、战略决策委员会委员职务，辞去上述职务后继续担任公司 副总裁。 董事、副总裁、董事会秘书张旭女士申请辞去公司董事、战略决策委员会委员职务，辞去上述职务后继 续担任公司副总裁、董事会秘书，其未持有公司股份。 董事邓拥军先生申请辞去公司董事、战略决策委员会委员职务，辞去上述职务后继 ...

8月10日晚，*ST赛隆（002898）公告称， 因公司控制权已发生变更，公司第四届董事会所有成员和部分高管均递交了辞职报告。 8月8日尾盘，*ST赛隆突然涨停。截至当日收盘，*ST赛隆股价报16.81元/股，涨幅达5%，总市值为29.6亿元。受益于并购重组概念，公司今 年来股价涨幅超70%。 | _SZSE CNY 15:00:00 闭市 | | | | | △ △ + | | --- | --- | --- | --- | --- | --- | | 委比 | 100.00% 委差 | 3884 | Wind ESG评级 B | | 详情 | | 卖五 | | | 令年 | 74.74% 120日 | 63.36% | | 卖四 | | | 5日 | 12.67% 250日 | 97.76% | | 英三 | | | 20日 | 24.80% 52周高 | 16.98 | | 卖二 | | | 60日 | 110.92% 52周低 | 5.77 | | 率一 | | | | 2023 2024 | 2025Q1 | | 际— | 16.81 | 3858 | EbS | 0.05 -0.19 | -0.0 ...

Core Viewpoint - *ST Sailong has undergone a change in control, leading to the resignation of all members of its fourth board of directors, including key executives and board members [1][3][4]. Group 1: Board Resignations - The entire fourth board of directors, consisting of 9 members, has submitted resignation reports, including Chairman Cai Nanguai and other key executives [3][4]. - Cai Nanguai will continue to hold other positions within the company after resigning as Chairman, President, and head of the Strategic Decision-Making Committee [3]. - Director Tang Lin has also resigned from all positions within the company, holding 722.39 million shares at the time of resignation [3][4]. Group 2: New Board Candidates - The company has proposed new candidates for the fourth board of directors, including 贾晋斌, 陈科, 陈顿斐, 张光扬, 陈榕辉, and 李童瑶 as non-independent directors, and 王淑芳, 张建民, and 张凯 as independent directors [4]. - The term for the newly nominated directors will last until the end of the current board's term [4]. Group 3: Financial Performance - *ST Sailong has projected a net loss of between 13 million and 18 million yuan for the first half of the year, compared to a profit of 176.47 thousand yuan in the same period last year [7]. - The company reported a basic loss per share of between 0.0739 yuan and 0.1023 yuan, contrasting with a profit of 0.0100 yuan per share in the previous year [7]. - As of August 8, the company's stock price closed at 16.81 yuan per share, with a total market capitalization of 2.959 billion yuan [8].

Core Viewpoint - *ST Sailong has experienced a complete resignation of its board members, indicating a significant change in corporate governance and potential implications for the company's future direction [1][3][4]. Board Resignation - All nine members of the fourth board of directors of *ST Sailong have submitted their resignation reports, including key figures such as Chairman Cai Nanguai and other executives [3][4]. - Cai Nanguai will continue to hold other positions within the company despite resigning as Chairman and CEO, and he holds 67.51 million shares, representing 47.23% of the company’s controlling shareholder [3][4]. - The resignations will lead to a board composition below the minimum required by the company's articles of association, necessitating the continuation of their roles until new directors are elected [4]. New Board Candidates - The board has proposed new candidates for the fourth board of directors, including non-independent and independent directors, to be elected at the upcoming shareholders' meeting [4][5]. Management Changes - The board has approved the appointment of Chen Ke as the new CEO, effective immediately following the board meeting [5]. - Chen Ke has a background in accounting and has held various positions in investment and asset management [6]. Financial Performance - *ST Sailong has projected a net loss of between 13 million and 18 million yuan for the first half of the year, a significant decline from a profit of 1.76 million yuan in the same period last year [7]. - The expected loss translates to a basic earnings per share loss of between 0.0739 yuan and 0.1023 yuan, compared to a profit of 0.0100 yuan per share in the previous year [7]. Stock Market Activity - On August 8, *ST Sailong's stock price reached a limit-up, closing at 16.81 yuan per share, with a total market capitalization of 2.959 billion yuan [7][8].

集体辞职。 *ST赛隆（002898）8月10日晚间公告称，因公司控制权已发生变更，公司于近日收到董事长兼总裁蔡南桂，董事唐霖，董事兼常务 副总裁刘达文，董事兼副总裁李剑峰，董事、副总裁、董事会秘书张旭，董事邓拥军，独立董事潘传云，独立董事陈小辛，独立董事 李公奋，副总裁王星递交的辞职报告。 值得一提的是，目前，*ST赛隆第四届董事会共有9名董事。这意味着，*ST赛隆第四届董事会的所有成员均递交了辞职报告。 其中，蔡南桂申请辞去董事长、董事、总裁、战略决策委员会主任委员职务，辞职后蔡南桂将继续担任公司其他职务。截至本公告披 露日，蔡南桂不存在应履行而未履行的承诺事项。 蔡南桂现持有公司股份6751.27万股 ，持有公司股东珠海横琴新区赛隆聚智投资有 限公司47.23%股权。 *ST赛隆在公告中指出，蔡南桂作为公司创始人、董事长，在任期间对公司的战略决策和合规治理、稳健经营等方面做出了重大贡 献，公司董事会对蔡南桂为公司发展所做出的卓越贡献表示诚挚的敬意和衷心感谢。 此外，唐霖申请辞去董事、战略决策委员会委员、审计委员会委员职务，辞去上述职务后唐霖不再担任公司任何职务。截至本公告披 露日，唐霖不存在应履行而未履 ...

8月10日晚间，*ST赛隆公告称，因公司控制权已发生变更，公司第四届董事会所有成员和部分高管均递交了辞职报告。 同时，海南雅亿共赢科技合伙企业（有限合伙）（以下简称海南雅亿）作为*ST赛隆的新任控股股东，提名贾晋斌等9人为*ST赛隆第四届董事会的董事候 选人。 8月8日尾盘，*ST赛隆突然涨停。截至当日收盘，*ST赛隆股价报16.81元/股，涨幅达5%，总市值为29.59亿元。 董事会所有成员辞职 *ST赛隆公告称，近日，公司收到董事长兼总裁蔡南桂、董事唐霖、董事兼常务副总裁刘达文、董事兼副总裁李剑峰、董事邓拥军、独立董事潘传云、独 立董事陈小辛、独立董事李公奋，以及董事、副总裁、董事会秘书张旭等9人递交的辞职报告。 *ST赛隆将迎新一任管理层 *ST赛隆公告称，蔡南桂等人申请辞去公司董事等职务，主要是公司控制权已经发生变更。 7月9日，*ST赛隆收到蔡南桂、唐霖与海南雅亿的通知，获悉蔡南桂、唐霖向海南雅亿协议转让所持*ST赛隆14.16%股份的过户登记手续已经办理完成， 并且取得中国证券登记结算有限责任公司出具的《证券过户登记确认书》。 目前，*ST赛隆第四届董事会共有9名董事。这意味着，*ST赛隆第四届董 ...